How 23andMe Quelled FDA Concerns About DTC Breast Cancer Gene Test

23AndMe ' s newest product tests for three variants of the BRCA gene that have been linked to breast and ovarian cancer, but the company had to take steps to guard against confusion and anxiety among customers.

Source: Forbes.com Healthcare News - March 23, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news